271 related articles for article (PubMed ID: 30735447)
1. 51 years in of Chikungunya clinical vaccine development: A historical perspective.
Reyes-Sandoval A
Hum Vaccin Immunother; 2019; 15(10):2351-2358. PubMed ID: 30735447
[TBL] [Abstract][Full Text] [Related]
2. Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development.
Rezza G; Weaver SC
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006919. PubMed ID: 30653504
[TBL] [Abstract][Full Text] [Related]
3. Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.
DeZure AD; Berkowitz NM; Graham BS; Ledgerwood JE
J Infect Dis; 2016 Dec; 214(suppl 5):S497-S499. PubMed ID: 27920180
[TBL] [Abstract][Full Text] [Related]
4. A patent perspective on chikungunya.
Dapurkar D; Telang M
Acta Trop; 2019 Nov; 199():105131. PubMed ID: 31401192
[TBL] [Abstract][Full Text] [Related]
5. Development of Vaccines for Chikungunya Fever.
Erasmus JH; Rossi SL; Weaver SC
J Infect Dis; 2016 Dec; 214(suppl 5):S488-S496. PubMed ID: 27920179
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates.
Rossi SL; Comer JE; Wang E; Azar SR; Lawrence WS; Plante JA; Ramsauer K; Schrauf S; Weaver SC
J Infect Dis; 2019 Jul; 220(5):735-742. PubMed ID: 31053842
[TBL] [Abstract][Full Text] [Related]
7. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
[TBL] [Abstract][Full Text] [Related]
8. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development.
de Lima Cavalcanti TYV; Pereira MR; de Paula SO; Franca RFO
Viruses; 2022 May; 14(5):. PubMed ID: 35632709
[TBL] [Abstract][Full Text] [Related]
9. Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus.
Yang S; Fink D; Hulse A; Pratt RD
Vaccine; 2017 Sep; 35(37):4851-4858. PubMed ID: 28760614
[TBL] [Abstract][Full Text] [Related]
10. Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine.
Zhang YN; Deng CL; Li JQ; Li N; Zhang QY; Ye HQ; Yuan ZM; Zhang B
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092567
[TBL] [Abstract][Full Text] [Related]
11. The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines.
Bettis AA; L'Azou Jackson M; Yoon IK; Breugelmans JG; Goios A; Gubler DJ; Powers AM
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010069. PubMed ID: 35020717
[TBL] [Abstract][Full Text] [Related]
12. Status of research and development of vaccines for chikungunya.
Smalley C; Erasmus JH; Chesson CB; Beasley DWC
Vaccine; 2016 Jun; 34(26):2976-2981. PubMed ID: 27026149
[TBL] [Abstract][Full Text] [Related]
13. Recent development in the strategies projected for chikungunya vaccine in humans.
Goyal M; Chauhan A; Goyal V; Jaiswal N; Singh S; Singh M
Drug Des Devel Ther; 2018; 12():4195-4206. PubMed ID: 30573950
[TBL] [Abstract][Full Text] [Related]
14. A chikungunya fever vaccine utilizing an insect-specific virus platform.
Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
[TBL] [Abstract][Full Text] [Related]
15. Chikungunya Virus Vaccines: Viral Vector-Based Approaches.
Ramsauer K; Tangy F
J Infect Dis; 2016 Dec; 214(suppl 5):S500-S505. PubMed ID: 27920181
[TBL] [Abstract][Full Text] [Related]
16. Chikungunya in Infants and Children: Is Pathogenesis Increasing?
Barr KL; Vaidhyanathan V
Viruses; 2019 Mar; 11(3):. PubMed ID: 30909568
[TBL] [Abstract][Full Text] [Related]
17. Vaccine and Therapeutic Options To Control Chikungunya Virus.
Powers AM
Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29237708
[TBL] [Abstract][Full Text] [Related]
18. Chikungunya virus and prospects for a vaccine.
Weaver SC; Osorio JE; Livengood JA; Chen R; Stinchcomb DT
Expert Rev Vaccines; 2012 Sep; 11(9):1087-101. PubMed ID: 23151166
[TBL] [Abstract][Full Text] [Related]
19. A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation.
Seymour RL; Adams AP; Leal G; Alcorn MD; Weaver SC
PLoS Negl Trop Dis; 2015; 9(6):e0003800. PubMed ID: 26115459
[TBL] [Abstract][Full Text] [Related]
20. Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines.
Salazar-González JA; Angulo C; Rosales-Mendoza S
Vaccine; 2015 Jul; 33(31):3650-8. PubMed ID: 26073010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
